The Thai government is facing criticism about its vaccine roll-out after it switched vaccine companies just two weeks out from its first phase.
Thailand had originally chosen the Chinese Sinovac jab, but is now moving forward with the one produced by Oxford-AstraZeneca.
That vaccine is set to be produced locally later in the year by a firm owned by the Thai king.
Al Jazeera's Scott Heidler reports from Bangkok, Thailand.
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#AlJazeeraEnglish #Thailand #COVID19
Thailand had originally chosen the Chinese Sinovac jab, but is now moving forward with the one produced by Oxford-AstraZeneca.
That vaccine is set to be produced locally later in the year by a firm owned by the Thai king.
Al Jazeera's Scott Heidler reports from Bangkok, Thailand.
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#AlJazeeraEnglish #Thailand #COVID19
- Category
- World
- Tags
- youtube, aljazeera.com, first phase
Sign in or sign up to post comments.
Be the first to comment